ValuEngine Downgrades HYPERA S A/S (HYPMY) to Sell

ValuEngine cut shares of HYPERA S A/S (OTCMKTS:HYPMY) from a hold rating to a sell rating in a research report report published on Friday morning.

Shares of HYPMY stock opened at $8.11 on Friday. The company has a debt-to-equity ratio of 0.05, a quick ratio of 2.77 and a current ratio of 3.22. HYPERA S A/S has a twelve month low of $6.31 and a twelve month high of $11.77.

HYPERA S A/S Company Profile

Hypera SA operates as a pharmaceutical company in Brazil. The company offers prescription medications under the Farmasa, Neo Química, and Luper brands; and over-the-counter medications comprising laxative, antacid, antispasmodic, topical antiseptic, topical, nasal decongestant, and other drugs under Gelol, Anapyon, Biotônico Fontoura, Epocler, Merthiolate, Tamarine, and Rinosoro brands.

Featured Story: Day Trading – Risk Worth the Reward?

To view ValuEngine’s full report, visit ValuEngine’s official website.

Receive News & Ratings for HYPERA S A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HYPERA S A/S and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply